Cabaletta Bio Inc (CABA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 97,277 | 101,429 | 108,679 | 112,097 | 131,003 |
| Marketable Securities | 4,751 | 7,233 | 8,062 | 7,698 | N/A |
| TOTAL | $105,756 | $113,535 | $119,218 | $123,471 | $134,122 |
| Non-Current Assets | |||||
| PPE Net | 1,227 | 890 | 980 | 806 | 739 |
| Investments And Advances | 0 | 0 | 1,333 | 3,383 | 0 |
| Other Non-Current Assets | 300 | 299 | 239 | 238 | 104 |
| TOTAL | $1,527 | $1,189 | $2,552 | $4,427 | $843 |
| Total Assets | $107,283 | $114,724 | $121,770 | $127,898 | $134,965 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,270 | 1,243 | 953 | 991 | 1,991 |
| Accrued Expenses | 2,699 | 3,937 | 3,312 | 2,272 | 1,265 |
| TOTAL | $3,969 | $5,180 | $4,265 | $3,263 | $3,256 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,969 | $5,180 | $4,265 | $3,263 | $3,256 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 24,928 | 24,063 | 24,055 | 24,040 | 24,034 |
| Retained earnings | -76,000 | -66,298 | -56,989 | -48,596 | -40,444 |
| Other shareholders' equity | 3 | 6 | 12 | 11 | 0 |
| TOTAL | $103,314 | $109,544 | $117,505 | $124,635 | $131,709 |
| Total Liabilities And Equity | $107,283 | $114,724 | $121,770 | $127,898 | $134,965 |